KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Treasury Shares (2016 - 2025)

Historic Treasury Shares for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $61.8 billion.

  • Merck's Treasury Shares rose 686.51% to $61.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 billion, marking a year-over-year increase of 686.51%. This contributed to the annual value of $58.3 billion for FY2024, which is 148.48% up from last year.
  • As of Q3 2025, Merck's Treasury Shares stood at $1.1 billion, which was up 428.27% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Merck's Treasury Shares registered a high of $1.1 billion during Q3 2025, and its lowest value of $1.0 billion during Q2 2023.
  • Moreover, its 5-year median value for Treasury Shares was $1.0 billion (2023), whereas its average is $1.0 billion.
  • Per our database at Business Quant, Merck's Treasury Shares crashed by 108.56% in 2022 and then soared by 686.51% in 2025.
  • Over the past 5 years, Merck's Treasury Shares (Quarter) stood at $57.1 billion in 2021, then fell by 1.09% to $56.5 billion in 2022, then grew by 1.7% to $57.4 billion in 2023, then grew by 1.48% to $58.3 billion in 2024, then rose by 6.0% to $61.8 billion in 2025.
  • Its Treasury Shares stands at $61.8 billion for Q3 2025, versus $60.5 billion for Q2 2025 and $59.4 billion for Q1 2025.